Drug News

Added 27 minutes ago Drug news

AbbVie to collaborate with Teneobio to develop TNB 383B for multiple myeloma.

AbbVie will partner with Teneobio and its affiliate TeneoOne, Inc., to develop and commercialize its lead program, the preclinical cancer...

Added 28 minutes ago Drug news

New company Arvelle Therapeutics secures EU rights to cenobamate for treatment of focal( partial offset) seizures.- Arvelle + SK Biopharmaceuticals

Axovant Sciences , a clinical-stage company developing innovative gene therapies, announces the formation of Arvelle Therapeutics and the strategic transition...

Added 1 day ago Drug news

Pivotal phase III data of Bavencio + Inlyta for renal cell carcinoma is published in NEJM.- Merck KGaA + Pfizer

Merck KGaA and Pfizer Inc. announced the publication of results from an interim analysis of the pivotal JAVELIN Renal 101...

Added 2 days ago Drug news

Darolutamide + ADT extends metastasis-free survival in non-metastatic castration-resistant prostate cancer. Bayer HealthCare

Results from the pivotal Phase III ARAMIS trial in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) showed a statistically significant...

Added 2 days ago Drug news

Bayer acquires global rights to Vitrakvi and Loxo 195.

Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to obtain the exclusive...

Added 2 days ago Drug news

FDA postpones PDUFA decision for Duobrii a proposed treatment for psoriasis.- Ortho Dermatologics

Bausch Health Companies Inc.and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, announced that...

Added 2 days ago Drug news

Genentech completes sBLA for Kadcyla for adjuvant treatment of HER2-positive early breast cancer (EBC) with residual disease.

Genentech, a member of the Roche Group announced completing the submission of a supplemental Biologics License Application to the FDA...

Added 3 days ago Drug news

CE Mark for Ascyrus Medical Dissection Stent-Ascyrus Medical

Ascyrus Medical, a privately-owned medical device company focused on innovative treatments for aortic dissections, announced the CE mark approval of...

Added 3 days ago Drug news

Opdivo + Yervoy success in CheckMate 650 trial for prostate cancer. -BMS

Bristol-Myers Squibb Company announced data evaluating Opdivo (nivolumab) in combination with Yervoy (ipilimumab) in patients with metastatic castration-resistant prostate cancer...

Added 4 days ago Drug news

FDA approves Egaten to treat fascioliasis.- Novartis

Novartis announced that the FDA has approved Egaten (triclabendazole) for the treatment of fascioliasis in patients six years of age...

Search all news articles